Third quarter trading update

NZX & ASX RELEASE Ryman Healthcare reports 375 sales of retirement living occupation right agreements (ORAs) for the quarter ending 31 December 2025 (Q3 FY26), including 101 new sales and 274 resales. Total sales were broadly flat on Q2 with a shift in mix across product types. As expected, new sales of independent living units eased following the opening of Nellie Melba Stage 4 in the prior quarter, while new sales of serviced apartments were strong across New Zealand and Australia. Resales were steady overall reflecting regional mix, with relocations from Margaret Stoddart and Woodcote to other Christchurch villages contributing. Occupancy continued to grow in Ryman’s recently opened aged care centres and remained strong in mature care centres at 96.0% in Q3, up from 95.8% in Q2. CEO Naomi James said, “We maintained sales momentum through to the holiday break, amid mixed housing market conditions and heightened competition continuing in some regions. We also continue to see growing demand for our high-quality care offering. While sales volumes are still rebuilding, we’re encouraged by clear progress in key metrics like contract conversion and cancellation rates – proof that our sales strategies are working, and lead quality is improving. Looking ahead, we expect continued market variability, but our focus remains firmly on driving sales effectiveness and controlling the factors within our reach.” FY26 ORA sales guidance remains unchanged at 1,300 – 1,400. Guidance excludes resident relocations from Margaret Stoddart and Woodcote following the closure of care centres at these villages (expected to be less than 40), which are included in reported sales volumes. Authorised by Morgan Powell General Counsel About Ryman Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49 retirement villages in New Zealand and Australia. Ryman villages are home to 15,300 residents, and the company employs 7,800 staff. Contacts For investor relations information Hayden Strickett, Head of Investor Relations hayden.strickett@rymanhealthcare.com For media information Sarah Greig, GM Corporate Affairs & Communication sarah.greig@rymanhealthcare.com